A Phase I Study of Escalated Dose Subcutaneous Alemtuzumab Given Weekly with Rituximab In Relapsed CLL/SLL

作者:Brown Jennifer R; Messmer Bradley; Werner Lillian; Mikler Evgeny; Fisher David C; LaCasce Ann; Armand Philippe; Jacobsen Eric D; Dalton Virginia; Tesar Bethany; Fernandes Stacey M; McDonough Sean; Ritz Jerome; Rassenti Laura Z; Kipps Thomas J; Neuberg Donna; Freedman Arnold S
来源:52nd Annual Meeting of the American-Society-of-Hematology (ASH), 2010-12-04 to 2010-12-07.
  • 出版日期2010-11-19